Global Immuno-Oncology Treatment Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Immuno-Oncology Treatment Industry Forecast” looks at past sales and reviews total world Immuno-Oncology Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Immuno-Oncology Treatment sales for 2023 through 2029. With Immuno-Oncology Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immuno-Oncology Treatment industry.
This Insight Report provides a comprehensive analysis of the global Immuno-Oncology Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Immuno-Oncology Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Immuno-Oncology Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immuno-Oncology Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immuno-Oncology Treatment.
The global Immuno-Oncology Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Immuno-Oncology Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Immuno-Oncology Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Immuno-Oncology Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Immuno-Oncology Treatment players cover Amgen, AstraZeneca, Bristol-Myers Squibb, Eli-Lilly, Roche, GlaxoSmithKline, Janssen Biotech, Merck and Novartis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Immuno-Oncology Treatment market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
LPI (LP Information)' newest research report, the “Immuno-Oncology Treatment Industry Forecast” looks at past sales and reviews total world Immuno-Oncology Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Immuno-Oncology Treatment sales for 2023 through 2029. With Immuno-Oncology Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immuno-Oncology Treatment industry.
This Insight Report provides a comprehensive analysis of the global Immuno-Oncology Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Immuno-Oncology Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Immuno-Oncology Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immuno-Oncology Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immuno-Oncology Treatment.
The global Immuno-Oncology Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Immuno-Oncology Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Immuno-Oncology Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Immuno-Oncology Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Immuno-Oncology Treatment players cover Amgen, AstraZeneca, Bristol-Myers Squibb, Eli-Lilly, Roche, GlaxoSmithKline, Janssen Biotech, Merck and Novartis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Immuno-Oncology Treatment market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Immune Checkpoint Inhibitors
- Monoclonal Antibodies
- Cytokine-Based Immunotherapy
- Cancer Vaccines
- CAR-T Cell Therapy
- Hospitals
- Ambulatory Surgical Center
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Amgen
- AstraZeneca
- Bristol-Myers Squibb
- Eli-Lilly
- Roche
- GlaxoSmithKline
- Janssen Biotech
- Merck
- Novartis
- Pfizer
- Sanofi
- Spectrum Pharmaceuticals
- Takeda
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Immuno-Oncology Treatment Market Size 2018-2029
2.1.2 Immuno-Oncology Treatment Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Immuno-Oncology Treatment Segment by Type
2.2.1 Immune Checkpoint Inhibitors
2.2.2 Monoclonal Antibodies
2.2.3 Cytokine-Based Immunotherapy
2.2.4 Cancer Vaccines
2.2.5 CAR-T Cell Therapy
2.3 Immuno-Oncology Treatment Market Size by Type
2.3.1 Immuno-Oncology Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Immuno-Oncology Treatment Market Size Market Share by Type (2018-2023)
2.4 Immuno-Oncology Treatment Segment by Application
2.4.1 Hospitals
2.4.2 Ambulatory Surgical Center
2.4.3 Others
2.5 Immuno-Oncology Treatment Market Size by Application
2.5.1 Immuno-Oncology Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Immuno-Oncology Treatment Market Size Market Share by Application (2018-2023)
3 IMMUNO-ONCOLOGY TREATMENT MARKET SIZE BY PLAYER
3.1 Immuno-Oncology Treatment Market Size Market Share by Players
3.1.1 Global Immuno-Oncology Treatment Revenue by Players (2018-2023)
3.1.2 Global Immuno-Oncology Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Immuno-Oncology Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 IMMUNO-ONCOLOGY TREATMENT BY REGIONS
4.1 Immuno-Oncology Treatment Market Size by Regions (2018-2023)
4.2 Americas Immuno-Oncology Treatment Market Size Growth (2018-2023)
4.3 APAC Immuno-Oncology Treatment Market Size Growth (2018-2023)
4.4 Europe Immuno-Oncology Treatment Market Size Growth (2018-2023)
4.5 Middle East & Africa Immuno-Oncology Treatment Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Immuno-Oncology Treatment Market Size by Country (2018-2023)
5.2 Americas Immuno-Oncology Treatment Market Size by Type (2018-2023)
5.3 Americas Immuno-Oncology Treatment Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immuno-Oncology Treatment Market Size by Region (2018-2023)
6.2 APAC Immuno-Oncology Treatment Market Size by Type (2018-2023)
6.3 APAC Immuno-Oncology Treatment Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Immuno-Oncology Treatment by Country (2018-2023)
7.2 Europe Immuno-Oncology Treatment Market Size by Type (2018-2023)
7.3 Europe Immuno-Oncology Treatment Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Immuno-Oncology Treatment by Region (2018-2023)
8.2 Middle East & Africa Immuno-Oncology Treatment Market Size by Type (2018-2023)
8.3 Middle East & Africa Immuno-Oncology Treatment Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL IMMUNO-ONCOLOGY TREATMENT MARKET FORECAST
10.1 Global Immuno-Oncology Treatment Forecast by Regions (2024-2029)
10.1.1 Global Immuno-Oncology Treatment Forecast by Regions (2024-2029)
10.1.2 Americas Immuno-Oncology Treatment Forecast
10.1.3 APAC Immuno-Oncology Treatment Forecast
10.1.4 Europe Immuno-Oncology Treatment Forecast
10.1.5 Middle East & Africa Immuno-Oncology Treatment Forecast
10.2 Americas Immuno-Oncology Treatment Forecast by Country (2024-2029)
10.2.1 United States Immuno-Oncology Treatment Market Forecast
10.2.2 Canada Immuno-Oncology Treatment Market Forecast
10.2.3 Mexico Immuno-Oncology Treatment Market Forecast
10.2.4 Brazil Immuno-Oncology Treatment Market Forecast
10.3 APAC Immuno-Oncology Treatment Forecast by Region (2024-2029)
10.3.1 China Immuno-Oncology Treatment Market Forecast
10.3.2 Japan Immuno-Oncology Treatment Market Forecast
10.3.3 Korea Immuno-Oncology Treatment Market Forecast
10.3.4 Southeast Asia Immuno-Oncology Treatment Market Forecast
10.3.5 India Immuno-Oncology Treatment Market Forecast
10.3.6 Australia Immuno-Oncology Treatment Market Forecast
10.4 Europe Immuno-Oncology Treatment Forecast by Country (2024-2029)
10.4.1 Germany Immuno-Oncology Treatment Market Forecast
10.4.2 France Immuno-Oncology Treatment Market Forecast
10.4.3 UK Immuno-Oncology Treatment Market Forecast
10.4.4 Italy Immuno-Oncology Treatment Market Forecast
10.4.5 Russia Immuno-Oncology Treatment Market Forecast
10.5 Middle East & Africa Immuno-Oncology Treatment Forecast by Region (2024-2029)
10.5.1 Egypt Immuno-Oncology Treatment Market Forecast
10.5.2 South Africa Immuno-Oncology Treatment Market Forecast
10.5.3 Israel Immuno-Oncology Treatment Market Forecast
10.5.4 Turkey Immuno-Oncology Treatment Market Forecast
10.5.5 GCC Countries Immuno-Oncology Treatment Market Forecast
10.6 Global Immuno-Oncology Treatment Forecast by Type (2024-2029)
10.7 Global Immuno-Oncology Treatment Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Amgen
11.1.1 Amgen Company Information
11.1.2 Amgen Immuno-Oncology Treatment Product Offered
11.1.3 Amgen Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Amgen Main Business Overview
11.1.5 Amgen Latest Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Information
11.2.2 AstraZeneca Immuno-Oncology Treatment Product Offered
11.2.3 AstraZeneca Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 AstraZeneca Main Business Overview
11.2.5 AstraZeneca Latest Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Information
11.3.2 Bristol-Myers Squibb Immuno-Oncology Treatment Product Offered
11.3.3 Bristol-Myers Squibb Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Bristol-Myers Squibb Main Business Overview
11.3.5 Bristol-Myers Squibb Latest Developments
11.4 Eli-Lilly
11.4.1 Eli-Lilly Company Information
11.4.2 Eli-Lilly Immuno-Oncology Treatment Product Offered
11.4.3 Eli-Lilly Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Eli-Lilly Main Business Overview
11.4.5 Eli-Lilly Latest Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Immuno-Oncology Treatment Product Offered
11.5.3 Roche Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Roche Main Business Overview
11.5.5 Roche Latest Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Information
11.6.2 GlaxoSmithKline Immuno-Oncology Treatment Product Offered
11.6.3 GlaxoSmithKline Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 GlaxoSmithKline Main Business Overview
11.6.5 GlaxoSmithKline Latest Developments
11.7 Janssen Biotech
11.7.1 Janssen Biotech Company Information
11.7.2 Janssen Biotech Immuno-Oncology Treatment Product Offered
11.7.3 Janssen Biotech Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Janssen Biotech Main Business Overview
11.7.5 Janssen Biotech Latest Developments
11.8 Merck
11.8.1 Merck Company Information
11.8.2 Merck Immuno-Oncology Treatment Product Offered
11.8.3 Merck Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Merck Main Business Overview
11.8.5 Merck Latest Developments
11.9 Novartis
11.9.1 Novartis Company Information
11.9.2 Novartis Immuno-Oncology Treatment Product Offered
11.9.3 Novartis Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Novartis Main Business Overview
11.9.5 Novartis Latest Developments
11.10 Pfizer
11.10.1 Pfizer Company Information
11.10.2 Pfizer Immuno-Oncology Treatment Product Offered
11.10.3 Pfizer Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Pfizer Main Business Overview
11.10.5 Pfizer Latest Developments
11.11 Sanofi
11.11.1 Sanofi Company Information
11.11.2 Sanofi Immuno-Oncology Treatment Product Offered
11.11.3 Sanofi Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Sanofi Main Business Overview
11.11.5 Sanofi Latest Developments
11.12 Spectrum Pharmaceuticals
11.12.1 Spectrum Pharmaceuticals Company Information
11.12.2 Spectrum Pharmaceuticals Immuno-Oncology Treatment Product Offered
11.12.3 Spectrum Pharmaceuticals Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Spectrum Pharmaceuticals Main Business Overview
11.12.5 Spectrum Pharmaceuticals Latest Developments
11.13 Takeda
11.13.1 Takeda Company Information
11.13.2 Takeda Immuno-Oncology Treatment Product Offered
11.13.3 Takeda Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Takeda Main Business Overview
11.13.5 Takeda Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Immuno-Oncology Treatment Market Size 2018-2029
2.1.2 Immuno-Oncology Treatment Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Immuno-Oncology Treatment Segment by Type
2.2.1 Immune Checkpoint Inhibitors
2.2.2 Monoclonal Antibodies
2.2.3 Cytokine-Based Immunotherapy
2.2.4 Cancer Vaccines
2.2.5 CAR-T Cell Therapy
2.3 Immuno-Oncology Treatment Market Size by Type
2.3.1 Immuno-Oncology Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Immuno-Oncology Treatment Market Size Market Share by Type (2018-2023)
2.4 Immuno-Oncology Treatment Segment by Application
2.4.1 Hospitals
2.4.2 Ambulatory Surgical Center
2.4.3 Others
2.5 Immuno-Oncology Treatment Market Size by Application
2.5.1 Immuno-Oncology Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Immuno-Oncology Treatment Market Size Market Share by Application (2018-2023)
3 IMMUNO-ONCOLOGY TREATMENT MARKET SIZE BY PLAYER
3.1 Immuno-Oncology Treatment Market Size Market Share by Players
3.1.1 Global Immuno-Oncology Treatment Revenue by Players (2018-2023)
3.1.2 Global Immuno-Oncology Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Immuno-Oncology Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 IMMUNO-ONCOLOGY TREATMENT BY REGIONS
4.1 Immuno-Oncology Treatment Market Size by Regions (2018-2023)
4.2 Americas Immuno-Oncology Treatment Market Size Growth (2018-2023)
4.3 APAC Immuno-Oncology Treatment Market Size Growth (2018-2023)
4.4 Europe Immuno-Oncology Treatment Market Size Growth (2018-2023)
4.5 Middle East & Africa Immuno-Oncology Treatment Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Immuno-Oncology Treatment Market Size by Country (2018-2023)
5.2 Americas Immuno-Oncology Treatment Market Size by Type (2018-2023)
5.3 Americas Immuno-Oncology Treatment Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immuno-Oncology Treatment Market Size by Region (2018-2023)
6.2 APAC Immuno-Oncology Treatment Market Size by Type (2018-2023)
6.3 APAC Immuno-Oncology Treatment Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Immuno-Oncology Treatment by Country (2018-2023)
7.2 Europe Immuno-Oncology Treatment Market Size by Type (2018-2023)
7.3 Europe Immuno-Oncology Treatment Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Immuno-Oncology Treatment by Region (2018-2023)
8.2 Middle East & Africa Immuno-Oncology Treatment Market Size by Type (2018-2023)
8.3 Middle East & Africa Immuno-Oncology Treatment Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL IMMUNO-ONCOLOGY TREATMENT MARKET FORECAST
10.1 Global Immuno-Oncology Treatment Forecast by Regions (2024-2029)
10.1.1 Global Immuno-Oncology Treatment Forecast by Regions (2024-2029)
10.1.2 Americas Immuno-Oncology Treatment Forecast
10.1.3 APAC Immuno-Oncology Treatment Forecast
10.1.4 Europe Immuno-Oncology Treatment Forecast
10.1.5 Middle East & Africa Immuno-Oncology Treatment Forecast
10.2 Americas Immuno-Oncology Treatment Forecast by Country (2024-2029)
10.2.1 United States Immuno-Oncology Treatment Market Forecast
10.2.2 Canada Immuno-Oncology Treatment Market Forecast
10.2.3 Mexico Immuno-Oncology Treatment Market Forecast
10.2.4 Brazil Immuno-Oncology Treatment Market Forecast
10.3 APAC Immuno-Oncology Treatment Forecast by Region (2024-2029)
10.3.1 China Immuno-Oncology Treatment Market Forecast
10.3.2 Japan Immuno-Oncology Treatment Market Forecast
10.3.3 Korea Immuno-Oncology Treatment Market Forecast
10.3.4 Southeast Asia Immuno-Oncology Treatment Market Forecast
10.3.5 India Immuno-Oncology Treatment Market Forecast
10.3.6 Australia Immuno-Oncology Treatment Market Forecast
10.4 Europe Immuno-Oncology Treatment Forecast by Country (2024-2029)
10.4.1 Germany Immuno-Oncology Treatment Market Forecast
10.4.2 France Immuno-Oncology Treatment Market Forecast
10.4.3 UK Immuno-Oncology Treatment Market Forecast
10.4.4 Italy Immuno-Oncology Treatment Market Forecast
10.4.5 Russia Immuno-Oncology Treatment Market Forecast
10.5 Middle East & Africa Immuno-Oncology Treatment Forecast by Region (2024-2029)
10.5.1 Egypt Immuno-Oncology Treatment Market Forecast
10.5.2 South Africa Immuno-Oncology Treatment Market Forecast
10.5.3 Israel Immuno-Oncology Treatment Market Forecast
10.5.4 Turkey Immuno-Oncology Treatment Market Forecast
10.5.5 GCC Countries Immuno-Oncology Treatment Market Forecast
10.6 Global Immuno-Oncology Treatment Forecast by Type (2024-2029)
10.7 Global Immuno-Oncology Treatment Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Amgen
11.1.1 Amgen Company Information
11.1.2 Amgen Immuno-Oncology Treatment Product Offered
11.1.3 Amgen Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Amgen Main Business Overview
11.1.5 Amgen Latest Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Information
11.2.2 AstraZeneca Immuno-Oncology Treatment Product Offered
11.2.3 AstraZeneca Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 AstraZeneca Main Business Overview
11.2.5 AstraZeneca Latest Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Information
11.3.2 Bristol-Myers Squibb Immuno-Oncology Treatment Product Offered
11.3.3 Bristol-Myers Squibb Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Bristol-Myers Squibb Main Business Overview
11.3.5 Bristol-Myers Squibb Latest Developments
11.4 Eli-Lilly
11.4.1 Eli-Lilly Company Information
11.4.2 Eli-Lilly Immuno-Oncology Treatment Product Offered
11.4.3 Eli-Lilly Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Eli-Lilly Main Business Overview
11.4.5 Eli-Lilly Latest Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Immuno-Oncology Treatment Product Offered
11.5.3 Roche Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Roche Main Business Overview
11.5.5 Roche Latest Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Information
11.6.2 GlaxoSmithKline Immuno-Oncology Treatment Product Offered
11.6.3 GlaxoSmithKline Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 GlaxoSmithKline Main Business Overview
11.6.5 GlaxoSmithKline Latest Developments
11.7 Janssen Biotech
11.7.1 Janssen Biotech Company Information
11.7.2 Janssen Biotech Immuno-Oncology Treatment Product Offered
11.7.3 Janssen Biotech Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Janssen Biotech Main Business Overview
11.7.5 Janssen Biotech Latest Developments
11.8 Merck
11.8.1 Merck Company Information
11.8.2 Merck Immuno-Oncology Treatment Product Offered
11.8.3 Merck Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Merck Main Business Overview
11.8.5 Merck Latest Developments
11.9 Novartis
11.9.1 Novartis Company Information
11.9.2 Novartis Immuno-Oncology Treatment Product Offered
11.9.3 Novartis Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Novartis Main Business Overview
11.9.5 Novartis Latest Developments
11.10 Pfizer
11.10.1 Pfizer Company Information
11.10.2 Pfizer Immuno-Oncology Treatment Product Offered
11.10.3 Pfizer Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Pfizer Main Business Overview
11.10.5 Pfizer Latest Developments
11.11 Sanofi
11.11.1 Sanofi Company Information
11.11.2 Sanofi Immuno-Oncology Treatment Product Offered
11.11.3 Sanofi Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Sanofi Main Business Overview
11.11.5 Sanofi Latest Developments
11.12 Spectrum Pharmaceuticals
11.12.1 Spectrum Pharmaceuticals Company Information
11.12.2 Spectrum Pharmaceuticals Immuno-Oncology Treatment Product Offered
11.12.3 Spectrum Pharmaceuticals Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Spectrum Pharmaceuticals Main Business Overview
11.12.5 Spectrum Pharmaceuticals Latest Developments
11.13 Takeda
11.13.1 Takeda Company Information
11.13.2 Takeda Immuno-Oncology Treatment Product Offered
11.13.3 Takeda Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Takeda Main Business Overview
11.13.5 Takeda Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Immuno-Oncology Treatment Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Immune Checkpoint Inhibitors
Table 3. Major Players of Monoclonal Antibodies
Table 4. Major Players of Cytokine-Based Immunotherapy
Table 5. Major Players of Cancer Vaccines
Table 6. Major Players of CAR-T Cell Therapy
Table 7. Immuno-Oncology Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Immuno-Oncology Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 9. Global Immuno-Oncology Treatment Market Size Market Share by Type (2018-2023)
Table 10. Immuno-Oncology Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 11. Global Immuno-Oncology Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 12. Global Immuno-Oncology Treatment Market Size Market Share by Application (2018-2023)
Table 13. Global Immuno-Oncology Treatment Revenue by Players (2018-2023) & ($ Millions)
Table 14. Global Immuno-Oncology Treatment Revenue Market Share by Player (2018-2023)
Table 15. Immuno-Oncology Treatment Key Players Head office and Products Offered
Table 16. Immuno-Oncology Treatment Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Immuno-Oncology Treatment Market Size by Regions 2018-2023 & ($ Millions)
Table 20. Global Immuno-Oncology Treatment Market Size Market Share by Regions (2018-2023)
Table 21. Global Immuno-Oncology Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 22. Global Immuno-Oncology Treatment Revenue Market Share by Country/Region (2018-2023)
Table 23. Americas Immuno-Oncology Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 24. Americas Immuno-Oncology Treatment Market Size Market Share by Country (2018-2023)
Table 25. Americas Immuno-Oncology Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 26. Americas Immuno-Oncology Treatment Market Size Market Share by Type (2018-2023)
Table 27. Americas Immuno-Oncology Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 28. Americas Immuno-Oncology Treatment Market Size Market Share by Application (2018-2023)
Table 29. APAC Immuno-Oncology Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 30. APAC Immuno-Oncology Treatment Market Size Market Share by Region (2018-2023)
Table 31. APAC Immuno-Oncology Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 32. APAC Immuno-Oncology Treatment Market Size Market Share by Type (2018-2023)
Table 33. APAC Immuno-Oncology Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 34. APAC Immuno-Oncology Treatment Market Size Market Share by Application (2018-2023)
Table 35. Europe Immuno-Oncology Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 36. Europe Immuno-Oncology Treatment Market Size Market Share by Country (2018-2023)
Table 37. Europe Immuno-Oncology Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 38. Europe Immuno-Oncology Treatment Market Size Market Share by Type (2018-2023)
Table 39. Europe Immuno-Oncology Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 40. Europe Immuno-Oncology Treatment Market Size Market Share by Application (2018-2023)
Table 41. Middle East & Africa Immuno-Oncology Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Immuno-Oncology Treatment Market Size Market Share by Region (2018-2023)
Table 43. Middle East & Africa Immuno-Oncology Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Immuno-Oncology Treatment Market Size Market Share by Type (2018-2023)
Table 45. Middle East & Africa Immuno-Oncology Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 46. Middle East & Africa Immuno-Oncology Treatment Market Size Market Share by Application (2018-2023)
Table 47. Key Market Drivers & Growth Opportunities of Immuno-Oncology Treatment
Table 48. Key Market Challenges & Risks of Immuno-Oncology Treatment
Table 49. Key Industry Trends of Immuno-Oncology Treatment
Table 50. Global Immuno-Oncology Treatment Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 51. Global Immuno-Oncology Treatment Market Size Market Share Forecast by Regions (2024-2029)
Table 52. Global Immuno-Oncology Treatment Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 53. Global Immuno-Oncology Treatment Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 54. Amgen Details, Company Type, Immuno-Oncology Treatment Area Served and Its Competitors
Table 55. Amgen Immuno-Oncology Treatment Product Offered
Table 56. Amgen Immuno-Oncology Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 57. Amgen Main Business
Table 58. Amgen Latest Developments
Table 59. AstraZeneca Details, Company Type, Immuno-Oncology Treatment Area Served and Its Competitors
Table 60. AstraZeneca Immuno-Oncology Treatment Product Offered
Table 61. AstraZeneca Main Business
Table 62. AstraZeneca Immuno-Oncology Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 63. AstraZeneca Latest Developments
Table 64. Bristol-Myers Squibb Details, Company Type, Immuno-Oncology Treatment Area Served and Its Competitors
Table 65. Bristol-Myers Squibb Immuno-Oncology Treatment Product Offered
Table 66. Bristol-Myers Squibb Main Business
Table 67. Bristol-Myers Squibb Immuno-Oncology Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 68. Bristol-Myers Squibb Latest Developments
Table 69. Eli-Lilly Details, Company Type, Immuno-Oncology Treatment Area Served and Its Competitors
Table 70. Eli-Lilly Immuno-Oncology Treatment Product Offered
Table 71. Eli-Lilly Main Business
Table 72. Eli-Lilly Immuno-Oncology Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 73. Eli-Lilly Latest Developments
Table 74. Roche Details, Company Type, Immuno-Oncology Treatment Area Served and Its Competitors
Table 75. Roche Immuno-Oncology Treatment Product Offered
Table 76. Roche Main Business
Table 77. Roche Immuno-Oncology Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 78. Roche Latest Developments
Table 79. GlaxoSmithKline Details, Company Type, Immuno-Oncology Treatment Area Served and Its Competitors
Table 80. GlaxoSmithKline Immuno-Oncology Treatment Product Offered
Table 81. GlaxoSmithKline Main Business
Table 82. GlaxoSmithKline Immuno-Oncology Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 83. GlaxoSmithKline Latest Developments
Table 84. Janssen Biotech Details, Company Type, Immuno-Oncology Treatment Area Served and Its Competitors
Table 85. Janssen Biotech Immuno-Oncology Treatment Product Offered
Table 86. Janssen Biotech Main Business
Table 87. Janssen Biotech Immuno-Oncology Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 88. Janssen Biotech Latest Developments
Table 89. Merck Details, Company Type, Immuno-Oncology Treatment Area Served and Its Competitors
Table 90. Merck Immuno-Oncology Treatment Product Offered
Table 91. Merck Main Business
Table 92. Merck Immuno-Oncology Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 93. Merck Latest Developments
Table 94. Novartis Details, Company Type, Immuno-Oncology Treatment Area Served and Its Competitors
Table 95. Novartis Immuno-Oncology Treatment Product Offered
Table 96. Novartis Main Business
Table 97. Novartis Immuno-Oncology Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 98. Novartis Latest Developments
Table 99. Pfizer Details, Company Type, Immuno-Oncology Treatment Area Served and Its Competitors
Table 100. Pfizer Immuno-Oncology Treatment Product Offered
Table 101. Pfizer Main Business
Table 102. Pfizer Immuno-Oncology Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 103. Pfizer Latest Developments
Table 104. Sanofi Details, Company Type, Immuno-Oncology Treatment Area Served and Its Competitors
Table 105. Sanofi Immuno-Oncology Treatment Product Offered
Table 106. Sanofi Immuno-Oncology Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 107. Sanofi Main Business
Table 108. Sanofi Latest Developments
Table 109. Spectrum Pharmaceuticals Details, Company Type, Immuno-Oncology Treatment Area Served and Its Competitors
Table 110. Spectrum Pharmaceuticals Immuno-Oncology Treatment Product Offered
Table 111. Spectrum Pharmaceuticals Main Business
Table 112. Spectrum Pharmaceuticals Immuno-Oncology Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 113. Spectrum Pharmaceuticals Latest Developments
Table 114. Takeda Details, Company Type, Immuno-Oncology Treatment Area Served and Its Competitors
Table 115. Takeda Immuno-Oncology Treatment Product Offered
Table 116. Takeda Main Business
Table 117. Takeda Immuno-Oncology Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 118. Takeda Latest Developments
Table 1. Immuno-Oncology Treatment Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Immune Checkpoint Inhibitors
Table 3. Major Players of Monoclonal Antibodies
Table 4. Major Players of Cytokine-Based Immunotherapy
Table 5. Major Players of Cancer Vaccines
Table 6. Major Players of CAR-T Cell Therapy
Table 7. Immuno-Oncology Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Immuno-Oncology Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 9. Global Immuno-Oncology Treatment Market Size Market Share by Type (2018-2023)
Table 10. Immuno-Oncology Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 11. Global Immuno-Oncology Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 12. Global Immuno-Oncology Treatment Market Size Market Share by Application (2018-2023)
Table 13. Global Immuno-Oncology Treatment Revenue by Players (2018-2023) & ($ Millions)
Table 14. Global Immuno-Oncology Treatment Revenue Market Share by Player (2018-2023)
Table 15. Immuno-Oncology Treatment Key Players Head office and Products Offered
Table 16. Immuno-Oncology Treatment Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Immuno-Oncology Treatment Market Size by Regions 2018-2023 & ($ Millions)
Table 20. Global Immuno-Oncology Treatment Market Size Market Share by Regions (2018-2023)
Table 21. Global Immuno-Oncology Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 22. Global Immuno-Oncology Treatment Revenue Market Share by Country/Region (2018-2023)
Table 23. Americas Immuno-Oncology Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 24. Americas Immuno-Oncology Treatment Market Size Market Share by Country (2018-2023)
Table 25. Americas Immuno-Oncology Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 26. Americas Immuno-Oncology Treatment Market Size Market Share by Type (2018-2023)
Table 27. Americas Immuno-Oncology Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 28. Americas Immuno-Oncology Treatment Market Size Market Share by Application (2018-2023)
Table 29. APAC Immuno-Oncology Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 30. APAC Immuno-Oncology Treatment Market Size Market Share by Region (2018-2023)
Table 31. APAC Immuno-Oncology Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 32. APAC Immuno-Oncology Treatment Market Size Market Share by Type (2018-2023)
Table 33. APAC Immuno-Oncology Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 34. APAC Immuno-Oncology Treatment Market Size Market Share by Application (2018-2023)
Table 35. Europe Immuno-Oncology Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 36. Europe Immuno-Oncology Treatment Market Size Market Share by Country (2018-2023)
Table 37. Europe Immuno-Oncology Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 38. Europe Immuno-Oncology Treatment Market Size Market Share by Type (2018-2023)
Table 39. Europe Immuno-Oncology Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 40. Europe Immuno-Oncology Treatment Market Size Market Share by Application (2018-2023)
Table 41. Middle East & Africa Immuno-Oncology Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Immuno-Oncology Treatment Market Size Market Share by Region (2018-2023)
Table 43. Middle East & Africa Immuno-Oncology Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Immuno-Oncology Treatment Market Size Market Share by Type (2018-2023)
Table 45. Middle East & Africa Immuno-Oncology Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 46. Middle East & Africa Immuno-Oncology Treatment Market Size Market Share by Application (2018-2023)
Table 47. Key Market Drivers & Growth Opportunities of Immuno-Oncology Treatment
Table 48. Key Market Challenges & Risks of Immuno-Oncology Treatment
Table 49. Key Industry Trends of Immuno-Oncology Treatment
Table 50. Global Immuno-Oncology Treatment Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 51. Global Immuno-Oncology Treatment Market Size Market Share Forecast by Regions (2024-2029)
Table 52. Global Immuno-Oncology Treatment Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 53. Global Immuno-Oncology Treatment Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 54. Amgen Details, Company Type, Immuno-Oncology Treatment Area Served and Its Competitors
Table 55. Amgen Immuno-Oncology Treatment Product Offered
Table 56. Amgen Immuno-Oncology Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 57. Amgen Main Business
Table 58. Amgen Latest Developments
Table 59. AstraZeneca Details, Company Type, Immuno-Oncology Treatment Area Served and Its Competitors
Table 60. AstraZeneca Immuno-Oncology Treatment Product Offered
Table 61. AstraZeneca Main Business
Table 62. AstraZeneca Immuno-Oncology Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 63. AstraZeneca Latest Developments
Table 64. Bristol-Myers Squibb Details, Company Type, Immuno-Oncology Treatment Area Served and Its Competitors
Table 65. Bristol-Myers Squibb Immuno-Oncology Treatment Product Offered
Table 66. Bristol-Myers Squibb Main Business
Table 67. Bristol-Myers Squibb Immuno-Oncology Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 68. Bristol-Myers Squibb Latest Developments
Table 69. Eli-Lilly Details, Company Type, Immuno-Oncology Treatment Area Served and Its Competitors
Table 70. Eli-Lilly Immuno-Oncology Treatment Product Offered
Table 71. Eli-Lilly Main Business
Table 72. Eli-Lilly Immuno-Oncology Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 73. Eli-Lilly Latest Developments
Table 74. Roche Details, Company Type, Immuno-Oncology Treatment Area Served and Its Competitors
Table 75. Roche Immuno-Oncology Treatment Product Offered
Table 76. Roche Main Business
Table 77. Roche Immuno-Oncology Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 78. Roche Latest Developments
Table 79. GlaxoSmithKline Details, Company Type, Immuno-Oncology Treatment Area Served and Its Competitors
Table 80. GlaxoSmithKline Immuno-Oncology Treatment Product Offered
Table 81. GlaxoSmithKline Main Business
Table 82. GlaxoSmithKline Immuno-Oncology Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 83. GlaxoSmithKline Latest Developments
Table 84. Janssen Biotech Details, Company Type, Immuno-Oncology Treatment Area Served and Its Competitors
Table 85. Janssen Biotech Immuno-Oncology Treatment Product Offered
Table 86. Janssen Biotech Main Business
Table 87. Janssen Biotech Immuno-Oncology Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 88. Janssen Biotech Latest Developments
Table 89. Merck Details, Company Type, Immuno-Oncology Treatment Area Served and Its Competitors
Table 90. Merck Immuno-Oncology Treatment Product Offered
Table 91. Merck Main Business
Table 92. Merck Immuno-Oncology Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 93. Merck Latest Developments
Table 94. Novartis Details, Company Type, Immuno-Oncology Treatment Area Served and Its Competitors
Table 95. Novartis Immuno-Oncology Treatment Product Offered
Table 96. Novartis Main Business
Table 97. Novartis Immuno-Oncology Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 98. Novartis Latest Developments
Table 99. Pfizer Details, Company Type, Immuno-Oncology Treatment Area Served and Its Competitors
Table 100. Pfizer Immuno-Oncology Treatment Product Offered
Table 101. Pfizer Main Business
Table 102. Pfizer Immuno-Oncology Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 103. Pfizer Latest Developments
Table 104. Sanofi Details, Company Type, Immuno-Oncology Treatment Area Served and Its Competitors
Table 105. Sanofi Immuno-Oncology Treatment Product Offered
Table 106. Sanofi Immuno-Oncology Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 107. Sanofi Main Business
Table 108. Sanofi Latest Developments
Table 109. Spectrum Pharmaceuticals Details, Company Type, Immuno-Oncology Treatment Area Served and Its Competitors
Table 110. Spectrum Pharmaceuticals Immuno-Oncology Treatment Product Offered
Table 111. Spectrum Pharmaceuticals Main Business
Table 112. Spectrum Pharmaceuticals Immuno-Oncology Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 113. Spectrum Pharmaceuticals Latest Developments
Table 114. Takeda Details, Company Type, Immuno-Oncology Treatment Area Served and Its Competitors
Table 115. Takeda Immuno-Oncology Treatment Product Offered
Table 116. Takeda Main Business
Table 117. Takeda Immuno-Oncology Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 118. Takeda Latest Developments
LIST OF FIGURES
Figure 1. Immuno-Oncology Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Immuno-Oncology Treatment Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Immuno-Oncology Treatment Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Immuno-Oncology Treatment Sales Market Share by Country/Region (2022)
Figure 8. Immuno-Oncology Treatment Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Immuno-Oncology Treatment Market Size Market Share by Type in 2022
Figure 10. Immuno-Oncology Treatment in Hospitals
Figure 11. Global Immuno-Oncology Treatment Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. Immuno-Oncology Treatment in Ambulatory Surgical Center
Figure 13. Global Immuno-Oncology Treatment Market: Ambulatory Surgical Center (2018-2023) & ($ Millions)
Figure 14. Immuno-Oncology Treatment in Others
Figure 15. Global Immuno-Oncology Treatment Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Immuno-Oncology Treatment Market Size Market Share by Application in 2022
Figure 17. Global Immuno-Oncology Treatment Revenue Market Share by Player in 2022
Figure 18. Global Immuno-Oncology Treatment Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Immuno-Oncology Treatment Market Size 2018-2023 ($ Millions)
Figure 20. APAC Immuno-Oncology Treatment Market Size 2018-2023 ($ Millions)
Figure 21. Europe Immuno-Oncology Treatment Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Immuno-Oncology Treatment Market Size 2018-2023 ($ Millions)
Figure 23. Americas Immuno-Oncology Treatment Value Market Share by Country in 2022
Figure 24. United States Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Immuno-Oncology Treatment Market Size Market Share by Region in 2022
Figure 29. APAC Immuno-Oncology Treatment Market Size Market Share by Type in 2022
Figure 30. APAC Immuno-Oncology Treatment Market Size Market Share by Application in 2022
Figure 31. China Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Immuno-Oncology Treatment Market Size Market Share by Country in 2022
Figure 38. Europe Immuno-Oncology Treatment Market Size Market Share by Type (2018-2023)
Figure 39. Europe Immuno-Oncology Treatment Market Size Market Share by Application (2018-2023)
Figure 40. Germany Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Immuno-Oncology Treatment Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Immuno-Oncology Treatment Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Immuno-Oncology Treatment Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 54. APAC Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 55. Europe Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 57. United States Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 58. Canada Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 61. China Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 62. Japan Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 63. Korea Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 65. India Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 66. Australia Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 67. Germany Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 68. France Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 69. UK Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 70. Italy Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 71. Russia Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 72. Spain Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 75. Israel Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 78. Global Immuno-Oncology Treatment Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Immuno-Oncology Treatment Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Immuno-Oncology Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Immuno-Oncology Treatment Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Immuno-Oncology Treatment Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Immuno-Oncology Treatment Sales Market Share by Country/Region (2022)
Figure 8. Immuno-Oncology Treatment Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Immuno-Oncology Treatment Market Size Market Share by Type in 2022
Figure 10. Immuno-Oncology Treatment in Hospitals
Figure 11. Global Immuno-Oncology Treatment Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. Immuno-Oncology Treatment in Ambulatory Surgical Center
Figure 13. Global Immuno-Oncology Treatment Market: Ambulatory Surgical Center (2018-2023) & ($ Millions)
Figure 14. Immuno-Oncology Treatment in Others
Figure 15. Global Immuno-Oncology Treatment Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Immuno-Oncology Treatment Market Size Market Share by Application in 2022
Figure 17. Global Immuno-Oncology Treatment Revenue Market Share by Player in 2022
Figure 18. Global Immuno-Oncology Treatment Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Immuno-Oncology Treatment Market Size 2018-2023 ($ Millions)
Figure 20. APAC Immuno-Oncology Treatment Market Size 2018-2023 ($ Millions)
Figure 21. Europe Immuno-Oncology Treatment Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Immuno-Oncology Treatment Market Size 2018-2023 ($ Millions)
Figure 23. Americas Immuno-Oncology Treatment Value Market Share by Country in 2022
Figure 24. United States Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Immuno-Oncology Treatment Market Size Market Share by Region in 2022
Figure 29. APAC Immuno-Oncology Treatment Market Size Market Share by Type in 2022
Figure 30. APAC Immuno-Oncology Treatment Market Size Market Share by Application in 2022
Figure 31. China Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Immuno-Oncology Treatment Market Size Market Share by Country in 2022
Figure 38. Europe Immuno-Oncology Treatment Market Size Market Share by Type (2018-2023)
Figure 39. Europe Immuno-Oncology Treatment Market Size Market Share by Application (2018-2023)
Figure 40. Germany Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Immuno-Oncology Treatment Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Immuno-Oncology Treatment Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Immuno-Oncology Treatment Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Immuno-Oncology Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 54. APAC Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 55. Europe Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 57. United States Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 58. Canada Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 61. China Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 62. Japan Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 63. Korea Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 65. India Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 66. Australia Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 67. Germany Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 68. France Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 69. UK Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 70. Italy Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 71. Russia Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 72. Spain Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 75. Israel Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Immuno-Oncology Treatment Market Size 2024-2029 ($ Millions)
Figure 78. Global Immuno-Oncology Treatment Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Immuno-Oncology Treatment Market Size Market Share Forecast by Application (2024-2029)
